Mitsubishi UFJ Capital

Triorb is a technology company focused on advancing robot mobility through innovative software and hardware solutions. It specializes in developing robotic technologies aimed at enhancing efficiency and safety within manufacturing environments. Triorb's movement system integrates a ball-driven omnidirectional mechanism with coordinated movement capabilities, enabling robots to transport various objects that cannot be handled by a single unit. This cooperative transportation system allows multiple robots to work together, improving operational effectiveness for businesses in need of automated solutions.

Aeterlink is a developer of advanced wireless power transfer technology aimed at eliminating the need for wires in various applications. The company specializes in creating wireless devices that can be applied across multiple fields, including factory automation, robotics, smart homes, and medicine. By enabling the wireless transmission of power over distances, Aeterlink's innovations enhance efficiency, sustainability, and safety in industries, allowing for greater flexibility in device placement and reducing the risks associated with traditional wiring. Their technology represents a significant step toward a digital world that operates without the constraints of physical connections.

Qibitech is a technology company focused on developing advanced robotic solutions and remote control services. It has created HATS, a system that allows a human operator to remotely enhance the functionality of robots, thereby improving their flexibility and efficiency. In addition to HATS, Qibitech offers a platform for integrating operational data with business improvement systems. The company specializes in contract development, provides research reports on technological trends and patents, and offers technical consulting related to intelligent robots and Internet of Things systems. By leveraging its expertise, Qibitech aims to help customers address their specific challenges and enhance their operational capabilities.

UGO specializes in the development of avatar robots and a comprehensive platform that facilitates the administration of multiple robots, aiming to enhance collaboration between humans and machines across various industries. The company addresses labor shortages in sectors such as security, inspection, manufacturing, healthcare, retail, and warehousing by providing robots that perform tasks traditionally handled by humans. These robots are designed for remote operation and feature artificial intelligence capabilities that enable them to operate autonomously under consistent conditions. UGO's solutions include assistance with housework, equipment inspection, and security in warehouses, promoting a new work model where human-robot collaboration is central to productivity and efficiency.

GITAI Inc. is a leading space robotics company based in Tokyo, Japan, established in 2016. The firm specializes in manufacturing humanoid telepresence robots to assist with tasks related to space exploration, particularly within space stations and lunar development. GITAI's product lineup includes the G1 robot, designed for general-purpose automation, the S1 robot for specific task automation, and the H1 manipulation system for remote operation of robots in space. By providing a reliable alternative to human labor, GITAI aims to enhance safety, improve efficiency, and significantly reduce operational costs in space activities. Their technology is intended to facilitate the construction and maintenance of satellites, space stations, and future habitats on the Moon and Mars, ultimately enabling more sustainable and cost-effective space exploration.

LexxPluss develops advanced automated transport robot systems tailored for logistics warehouses, addressing the ongoing labor shortage exacerbated by the surge in online shopping. The company's robots employ both autonomous and guided driving modes, allowing them to navigate complex environments with precision. By focusing on cost-effectiveness, on-site safety, and user experience, LexxPluss aims to help businesses automate operations that have traditionally relied heavily on human labor. This innovative approach not only enhances operational efficiency but also improves the safety of essential workers in the field, ultimately supporting the logistics industry’s evolving needs.

Mira Robotics is a software based company provide services that can robots in various fields.

Blue Innovation Co., Ltd. specializes in the development of advanced solutions for unmanned aerial vehicles (UAVs), focusing on inspection, education, logistics, and more. The company utilizes its proprietary Blue Earth Platform, which facilitates digital transformation and automation through remote, beyond-visual-line-of-sight (BVLOS) control of multiple drones, robots, and various devices. This innovative platform supports a range of research and development projects aimed at enhancing the operational capabilities of UAVs. Additionally, Blue Innovation plays a vital role in the Japan UAS Industry Promotion Council (JUIDA), contributing to its administrative functions and promoting the growth of the unmanned aerial systems sector in Japan.

Mira Robotics is a software based company provide services that can robots in various fields.

Araya Inc. is a Tokyo-based company that specializes in developing artificial intelligence software solutions. Founded in 2013, the company focuses on deep learning algorithms that facilitate real-time image recognition and processing services, enabling the identification of various individuals and objects in images and videos. Araya's technology also includes deep reinforcement learning, allowing for the autonomous movement of drones and robots. Additionally, the company has developed a unique deep learning compression technology that enhances the efficiency of its algorithms, making them smaller and faster while maintaining accuracy. By aiming to advance the capabilities of artificial intelligence towards potential artificial consciousness, Araya seeks to address the diverse needs of its clients through innovative AI services.

Cyfuse Biomedical K.K. is a biotechnology company based in Tokyo, Japan, that specializes in the research, development, and commercialization of tissue fabrication systems and cell-based products. Founded in 2010, the company offers 3D BioFabrication systems that utilize robotic technology to assemble spheroids into customized 3D shapes, providing innovative solutions for cell delivery in research and therapeutic applications. Cyfuse develops and licenses 3D tissue products for therapeutic use and engages in contract manufacturing for research purposes. The applications of its products include blood vessel grafts for hemodialysis access and coronary artery bypass grafts, cardiac grafts for drug toxicology and myocardial infarction therapy, cartilage grafts for surgical reconstruction, and hepatocyte grafts for drug metabolism studies and hemophilia treatment. Cyfuse Biomedical serves various research and development institutes, including universities, and has established a strategic partnership with Shibuya Kogyo Co., Ltd.

Kyoto Robotics Corporation is a robotics and automation company based in Kusatsu, Japan, founded in 2000. The company specializes in developing intelligent picking robots tailored for logistics systems, focusing on applications such as palletizing and piece-picking. Kyoto Robotics offers advanced solutions that incorporate a 3D robot vision system capable of object recognition and pose estimation, allowing the robots to intelligently navigate and control their movements. In addition to its robotic products, the company also provides technical support services to ensure effective integration and operation. Formerly known as 3D MEDiA Co., Ltd., Kyoto Robotics adopted its current name in January 2018.

Cyfuse Biomedical K.K. is a biotechnology company based in Tokyo, Japan, that specializes in the research, development, and commercialization of tissue fabrication systems and cell-based products. Founded in 2010, the company offers 3D BioFabrication systems that utilize robotic technology to assemble spheroids into customized 3D shapes, providing innovative solutions for cell delivery in research and therapeutic applications. Cyfuse develops and licenses 3D tissue products for therapeutic use and engages in contract manufacturing for research purposes. The applications of its products include blood vessel grafts for hemodialysis access and coronary artery bypass grafts, cardiac grafts for drug toxicology and myocardial infarction therapy, cartilage grafts for surgical reconstruction, and hepatocyte grafts for drug metabolism studies and hemophilia treatment. Cyfuse Biomedical serves various research and development institutes, including universities, and has established a strategic partnership with Shibuya Kogyo Co., Ltd.

Kyoto Robotics Corporation is a robotics and automation company based in Kusatsu, Japan, founded in 2000. The company specializes in developing intelligent picking robots tailored for logistics systems, focusing on applications such as palletizing and piece-picking. Kyoto Robotics offers advanced solutions that incorporate a 3D robot vision system capable of object recognition and pose estimation, allowing the robots to intelligently navigate and control their movements. In addition to its robotic products, the company also provides technical support services to ensure effective integration and operation. Formerly known as 3D MEDiA Co., Ltd., Kyoto Robotics adopted its current name in January 2018.

Mu Lab Inc. is a robotics company based in Fukushima, Japan, specializing in the design, manufacture, and sale of robotic parts and products. The company focuses on advancing robotics technology to meet various industry needs, contributing to innovation in the field.

HiBot is a Tokyo-based company founded in 2004 that specializes in robotic systems and related hardware and software solutions. The company develops robotic platforms designed for hazardous operations, infrastructure maintenance and inspection, and search and rescue missions. HiBot offers robots as a service, providing clients with advanced systems that facilitate data acquisition, management, and real-time visualization. Their technology incorporates artificial intelligence for defect detection, allowing organizations to enhance safety by automating dangerous or repetitive tasks.

Through us it is, provides the development of co-robot to help people, People will contribute to the creation of new value.

Through us it is, provides the development of co-robot to help people, People will contribute to the creation of new value.

INNOPHYS is developing, designing, manufacturing, consulting and distributing robotics equipment for various industries. Their flagship product, Muscle Suit® is a wearable robot supported by artificial muscle technology, well known for its high quality and reasonable price compared with the same kind of support exoskeletons. The company is planning to expand its business to Asia Pacific, Europe, and North America.

Cyfuse Biomedical K.K. is a biotechnology company based in Tokyo, Japan, that specializes in the research, development, and commercialization of tissue fabrication systems and cell-based products. Founded in 2010, the company offers 3D BioFabrication systems that utilize robotic technology to assemble spheroids into customized 3D shapes, providing innovative solutions for cell delivery in research and therapeutic applications. Cyfuse develops and licenses 3D tissue products for therapeutic use and engages in contract manufacturing for research purposes. The applications of its products include blood vessel grafts for hemodialysis access and coronary artery bypass grafts, cardiac grafts for drug toxicology and myocardial infarction therapy, cartilage grafts for surgical reconstruction, and hepatocyte grafts for drug metabolism studies and hemophilia treatment. Cyfuse Biomedical serves various research and development institutes, including universities, and has established a strategic partnership with Shibuya Kogyo Co., Ltd.

CyberHeart, Inc. is a clinical development-stage company based in Mountain View, California, focused on creating a non-invasive robotic ablation treatment for cardiac arrhythmias, including conditions like atrial fibrillation and ventricular tachycardia. The company's flagship product, the CyberHeart System, utilizes advanced technology to dynamically detect, track, and compensate for the movement of both the heart and the patient, ensuring precise radiation delivery. This system is designed for use by healthcare professionals such as radiation oncologists, medical physicists, electrophysiologists, and cardiac surgeons. Founded in 2003 and operating as a subsidiary of Varian Medical Systems as of April 2019, CyberHeart has been conducting pre-clinical studies to validate the feasibility of its innovative technology. The company has also secured venture capital financing to support its development efforts.